MRI for Prostate Cancer
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that mpMRI is effective in accurately locating prostate cancer, improving risk assessment, and aiding in treatment decisions. It helps in diagnosing, staging, and evaluating treatment responses, making it a valuable tool in managing prostate cancer.
12345The research articles do not provide specific safety data for multiparametric MRI, but it is widely used in prostate cancer detection and monitoring, suggesting it is generally considered safe.
678910Multiparametric MRI (mpMRI) is unique because it is a non-invasive imaging technique that provides detailed functional information about the prostate, helping to accurately distinguish between benign and malignant lesions. Unlike other treatments, it serves as a highly effective diagnostic tool, improving the localization of prostate cancer and aiding in better clinical decision-making.
13111213Eligibility Criteria
This trial is for men recently diagnosed with prostate cancer who are candidates for definitive surgery. It's not open to those who've had previous treatments for prostate cancer, major pelvic surgeries like hip replacements, or can't have an MRI due to severe claustrophobia, certain metal implants, kidney failure, or exceeding the scanner's weight limit.Inclusion Criteria
Exclusion Criteria
Participant Groups
- Prostate cancer staging
- Prostate cancer treatment planning
- Active surveillance of low-risk prostate cancer
- Prostate cancer detection
- Prostate cancer staging
- Prostate cancer treatment planning
- Active surveillance of low-risk prostate cancer
- Prostate cancer detection
- Prostate cancer staging
- Prostate cancer treatment planning